MedTrace Logo

Evaluation of Blastocyst Morphology and Quality in Patients With Embryo Transfer at the Blastocyst Stage

NCT05510557 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-05-23

No results posted yet for this study

Summary

In this prospective study, the investigators aim to investigate the role of trophectoderm cells and inner cell mass cells on pregnancy outcomes in blastocyst transferred in-vitro fertilization pregnancy. The investigators will support findings with bilateral uterine artery Doppler measurements to be made between the 11th and 14th weeks of pregnancy.

Conditions

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Principal Investigators

  • Şafak Olgan, MD · 1

  • Arif C Özsipahi, MD · 2

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-07-31
Completion
2023-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05510557 on ClinicalTrials.gov